直接植入作为即刻乳房再造一线选择:与两阶段再造的比较研究
本研究回顾性分析2011年1月至2016年12月间即刻单阶段直接植入乳房再造(SSR)与两阶段组织扩张器再造(TSR)的安全性,两组均使用脱细胞真皮基质。共298例乳房手术(SSR 233例,TSR 65例),SSR手术成功率97%高于TSR的90.2%(P=0.03),TSR血肿、血清肿和植入失败率显著更高,皮肤坏死率TSR较低但仅接近显著(P=0.053)。作者认为SSR并发症率更低且挽救成功率更高,可考虑作为乳房再造的一线方法。
要点
- SSR手术成功率97%高于TSR的90.2%(P=0.03)。
- TSR血肿率12.3% vs SSR 3.4%(P=0.005),血清肿率41.5% vs 20.6%(P=0.001),植入失败率9.8% vs 3.0%(P=0.03)。
- SSR植入挽救率61.1%高于TSR的12.5%(P=0.013)。
核心结论
- 单阶段再造的并发症率低于两阶段再造;SSR的高挽救率使得尽管可能需要修手术,对植入失败的担忧较少,因此SSR可考虑作为乳房再造的一线方法,无需患者选择干预。
研究设计与样本
- 回顾性分析2011年1月至2016年12月间进行的即刻单阶段直接植入乳房再造(SSR)与使用组织扩张器的两阶段再造(TSR),两组均使用脱细胞真皮基质以维持相似的腔隙条件,患者选择未考虑风险因素。
- 共纳入290例患者(含8例双侧乳房再造),手术乳房共298例,其中SSR 233例(78%),TSR 65例(22%)。
主要发现
- 手术成功率(即植入物维持未取出)SSR为97%,TSR为90.2%(P=0.03)。
- TSR血肿发生率12.3% vs SSR 3.4%(P=0.005),血清肿发生率41.5% vs SSR 20.6%(P=0.001),植入失败率9.8% vs SSR 3.0%(P=0.03)。
- 皮肤坏死率TSR为7.7% vs SSR 10.3%,差异接近显著(P=0.053)。
- 即使经过修手术后,SSR的植入物挽救率61.1%仍高于TSR的12.5%(P=0.013)。
临床怎么用
- 作者认为SSR可考虑作为乳房再造的一线方法,无需患者选择干预。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Immediate single-stage direct-to-implant breast reconstruction requires caution owing to the possibility of skin necrosis and implant failure. Nevertheless, this method has been performed widely for breast reconstruction. This study aimed to analyze the safety of single-stage implant reconstruction by comparing it with 2-stage reconstruction (TSR). METHODS: Immediate single-stage reconstructions (SSRs) and TSRs with a tissue expander, performed from January 2011 to December 2016, were retrospectively reviewed. Acellular dermal matrix was used in both groups to maintain similar pocket conditions. Risk factors were not considered in patient selection. RESULTS: We enrolled 290 patients including 8 who received bilateral breast reconstruction. A total of 298 breasts were operated, including 233 SSR cases (78%) and 65 TSR cases (22%). The surgical success (ie, the implant was maintained without explantation) rate was higher in SSR (97%) than in TSR (90.2%) (P = 0.03). Two-stage reconstruction had a significantly higher rate of hematoma (12.3% vs 3.4%, P = 0.005), seroma (41.5% vs 20.6%, P = 0.001), and implant failure (9.8% vs 3.0%, P = 0.03). However, the rate of skin necrosis was lower in TSR (7.7% vs 10.3%) with a trend toward significance (P = 0.053). The implant salvage rate was higher in SSR (61.1%) than in TSR (12.5%) even after revision operation (P = 0.013). CONCLUSIONS: Single-stage reconstruction yielded a lower complication rate than TSR. Moreover, the high salvage rate of SSR causes less concern about implant failure despite the possibility of revision operation. Therefore, SSR may be considered a frontline method for breast reconstruction without any patient selection interference.
引用
- Han HH, Kim HB, Kim EK, et al. Direct-to-Implant as a Frontline Option for Immediate Breast Reconstruction: A Comparative Study With 2-Stage Reconstruction. Ann Plast Surg. 2018. PMID: 29916885. doi:10.1097/SAP.0000000000001517
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。